Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Cholera: Individualised risk assessment for travellers
Cholera: Individualised risk assessment for travellers

We are on our summer break and the editorial office is closed until 13 January. In the meantime, please enjoy our Summer Hiatus series, in which our journalists curate an eclectic mix from our news and clinical archives throughout the year, The Conversation and other publications we share content with. Please note the comment function has been turned off while we are away. Happy reading!
This article was first published online on 31 July 2024.
This article summarises three papers about cholera, including the global situation, a new vaccine on its way, and guidelines on who should get vaccinated
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
1. WHO. Multi-country outbreak of cholera. External Situation Report n. 15. 19 June 2024.
2. Levine MM, Chen WH, Kaper JB, et al. PaxVax CVD 103-HgR single-dose live oral cholera vaccine. Expert Rev Vaccines 2017;16(3):197–213.
3. López-Vélez R, Presotto D. Cholera in travellers: improving vaccination guidance in Europe. J Travel Med 2021;28(1):taaa209.